Polpharma Indapen Retard Prolonged-Release Tablets 1.5mg, 30 pcs

Overview

Indapen Retard prolonged-release tablets contain the active substance indapamide, a diuretic used to manage fluid balance. Each tablet provides 1.5mg of indapamide in a prolonged-release formulation, allowing for once-daily dosing. This pack contains 30 tablets (2 blisters of 15).

Manufactured by Pharmaceutical Works Polpharma S.A. in Poland, these tablets are designed for consistent delivery of the active ingredient. Indapen Retard is intended for use under medical supervision as part of a treatment plan for conditions requiring diuretic therapy.

Why You'll Like It

• Prolonged-release formulation for once-daily convenience
• Consistent dosing from a trusted Polish manufacturer
• Compact blister packaging for easy storage and portability
• Clear dosage strength marked on each tablet

Who It's For

• Individuals prescribed indapamide for fluid management
• Buyers looking for a prolonged-release tablet form
• Those who prefer a well-established European pharmaceutical brand
• Patients needing a 30-tablet supply for monthly use

Package Details

• Pack contents: 30 tablets (2 blisters of 15 tablets each)
• Dosage form: Prolonged-release film-coated tablets
• Strength: 1.5mg indapamide per tablet

Common Questions